Transcriptional signature of lymphoblastoid cell lines ofBRCA1,BRCA2and non-BRCA1/2high risk breast cancer families
Open Access
- 12 August 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (45) , 78691-78712
Abstract
Transcriptional signature of lymphoblastoid cell lines of BRCA1 , BRCA2 and non- BRCA1/2 high risk breast cancer families Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer familiesKeywords
This publication has 137 references indexed in Scilit:
- 14-3-3 proteins as signaling integration points for cell cycle control and apoptosisSeminars in Cell & Developmental Biology, 2011
- Exonic expression profiling of breast cancer and benign lesions: a retrospective analysisThe Lancet Oncology, 2009
- A genome-wide association study of global gene expressionNature Genetics, 2007
- Hepatoma‐derived growth factor is a novel prognostic factor for gastrointestinal stromal tumorsInternational Journal of Cancer, 2007
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analysesInternational Journal of Cancer, 2005
- Genetic analysis of genome-wide variation in human gene expressionNature, 2004
- Expression of hepatoma‐derived growth factor in hepatocellular carcinomaCancer, 2003
- Natural variation in human gene expression assessed in lymphoblastoid cellsNature Genetics, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002